Each synthesis is unique. The resulting yield is dependent on the sequence composition, length, and purification method; it is also impacted by other variables introduced in the manufacturing process such as chemistry lot, synthesizer, etc.
Our synthesis and QC processes did not change with the unit of measure switch to nanomoles (December 2019). The lower yield from this synthesis is likely a result of the variability that is inherent to the process for nucleic acid synthesis.
*RUO—For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.